Dystrophin-deficient cardiomyopathy

F Kamdar, DJ Garry - Journal of the American College of Cardiology, 2016 - jacc.org
Dystrophinopathies are a group of distinct neuromuscular diseases that result from
mutations in the structural cytoskeletal Dystrophin gene. Dystrophinopathies include …

Management of cardiac involvement associated with neuromuscular diseases: a scientific statement from the American Heart Association

B Feingold, WT Mahle, S Auerbach, P Clemens… - Circulation, 2017 - Am Heart Assoc
For many neuromuscular diseases (NMDs), cardiac disease represents a major cause of
morbidity and mortality. The management of cardiac disease in NMDs is made challenging …

Assessment of systemic delivery of rAAVrh74. MHCK7. micro-dystrophin in children with Duchenne muscular dystrophy: a nonrandomized controlled trial

JR Mendell, Z Sahenk, K Lehman, C Nease… - JAMA …, 2020 - jamanetwork.com
Importance Micro-dystrophin gene transfer shows promise for treating patients with
Duchenne muscular dystrophy (DMD) using recombinant adeno-associated virus serotype …

Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines

PF Kantor, J Lougheed, A Dancea, M McGillion… - Canadian journal of …, 2013 - Elsevier
Pediatric heart failure (HF) is an important cause of morbidity and mortality in childhood. This
article presents guidelines for the recognition, diagnosis, and early medical management of …

JCS/JHFS 2018 guideline on the diagnosis and treatment of cardiomyopathies

H Kitaoka, H Tsutsui, T Kubo, T Ide, T Chikamori… - Circulation …, 2021 - jstage.jst.go.jp
The classes of recommendations and levels of evidence in these guidelines were
determined and described according to the “Guidelines for the treatment of acute and …

Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery …

H Baccouche, H Mahrholdt, G Meinhardt… - European heart …, 2009 - academic.oup.com
Aims Only few data are available regarding a direct comparison of both non-invasive CMR
and invasive EMB with respect to conformity of procedure-derived diagnoses in the same …

Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations

D Verhaert, K Richards, JA Rafael-Fortney… - Circulation …, 2011 - Am Heart Assoc
Muscular dystrophy (MD) connotes a heterogeneous group of inherited disorders
characterized by progressive wasting and weakness of the skeletal muscles. In several …

Female dystrophinopathy: Review of current literature

M Ishizaki, M Kobayashi, K Adachi, T Matsumura… - Neuromuscular …, 2018 - Elsevier
Skeletal muscle or cardiac symptoms are known to appear in a certain proportion of female
patients carrying the dystrophin gene mutation. There is limited high-quality evidence to …

Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy …

DM Connuck, LA Sleeper, SD Colan, GF Cox… - American heart …, 2008 - Elsevier
OBJECTIVE: The aim of this study was to determine in pediatric Duchenne (DMD) and
Becker muscular dystrophy (BMD) or other dilated cardiomyopathies (ODCM) whether …

Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy

A Tandon, CR Villa, KN Hor, JL Jefferies… - Journal of the …, 2015 - Am Heart Assoc
Background Patients with Duchenne muscular dystrophy exhibit progressive cardiac and
skeletal muscle dysfunction. Based on prior data, cardiac dysfunction in Duchenne muscular …